Novo Nordisk
The Partners hires creative director from InVentive
June 30, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw
Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team. …
EMA waves through a raft of drug recommendations
June 26, 2015Research and Development, Sales and Marketing AbbVie, Alexion, CHMP, EMA, Novartis, Novo Nordisk, brett wells
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …
Novo Nordisk launches diabetes combination
June 8, 2015Sales and Marketing Novo Nordisk, Xutolphy, ada, diabetes
Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …
Lundbeck gains new chief executive from Novo Nordisk
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen
Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …
Novo Nordisk invests in haemophilia with Denmark facility
May 5, 2015Manufacturing and Production, Sales and Marketing Novo Nordisk, diabetes, haemophilia, novoseven
Novo Nordisk is spending around $225 million on a new facility in Kalundborg, Denmark to produce active pharmaceutical ingredients for haemophilia …
Novo Nordisk obesity drug is launched in the US
April 23, 2015Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization
Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …
Novo Nordisk opens insulin plant in Russia
April 10, 2015Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill
Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …
FDA to look again at Novo Nordisk insulin submissions
April 8, 2015Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec
Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …
Novo resubmits FDA application for two diabetes drugs
March 27, 2015Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes
Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …
Novo Nordisk obesity drug shows added benefits
March 9, 2015Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight
New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …
UK pharma commits at least ‘one code breach a week’
February 18, 2015Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code
Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …
Hospira closing US manufacturing plant
January 20, 2015Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing
US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …
Novo Nordisk obesity drug gets FDA nod
December 24, 2014Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda
The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …
GSK tops pharma league for access
November 17, 2014Sales and Marketing Africa, GSK, Novo Nordisk, access, market, vaccines
GlaxoSmithKline is basking in some good news after topping the league table of pharma companies which do the most to …
Novo Nordisk to open $130 million diabetes labs
November 3, 2014Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes
Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …
